In the chaotic world of hospital operations, Bluesight isn't just managing data—they're building the central nervous system for modern pharmacies and hospitals. With $44.5M in funding and $60.7M in revenue, they're turning operational chaos into compliance and profit.

"They're not just selling software—they're selling compliance, efficiency, and the peace of mind that comes with knowing exactly where every controlled substance ends up."

The leadership team tells the story of execution. Kevin MacDonald and David Brzozowski split CEO roles—a structure that suggests either strategic complexity or internal tension. Scott Person, a pharmacist turned Product Owner, bridges the clinical and technical worlds. Mark Peters (CFO) and Vijay Venkatesh (CTO) represent the classic scaling duo: one managing burn rate, the other scaling infrastructure. This isn't a founder-only startup anymore; it's a professional organization built for enterprise sales cycles.

• Hospital intelligence platform that unifies operations, finances, and compliance into a single view
• KitCheck integration creates a moat in pharmacy inventory management—competitors can't easily replicate the workflow lock-in
• Patient privacy monitoring suggests they're expanding beyond controlled substances into broader compliance monitoring
• 199 employees indicates they're past the scrappy startup phase and into serious enterprise scaling